SCHEMBL31074207

SCHEMBL31074207

OCC[C@H](O)c1cccc(Cl)c1Cl

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.48
CYP1A2 P05177 3/20 0.46
CYP2D6 P10635 3/20 0.46
NFKB1 P19838 2/20 0.46
PNMT P11086 2/20 0.46
CYP3A4 P08684 2/20 0.46
ALDH1A1 P00352 1/20 0.44
LMNA P02545 1/20 0.44
GLA P06280 1/20 0.44
CYP2C19 P33261 2/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
TSHR P16473 1/20 0.39
ADRB2 P07550 2/20 0.39
ADRB1 P08588 2/20 0.39
AOC3 Q16853 1/20 0.39
IDO1 P14902 1/20 0.38
TDO2 P48775 1/20 0.38
HIF1A Q16665 1/20 0.38
BLM P54132 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3190822 1.00 KCNH2 (0.48) KCNH2CYP1A2CYP2D6NFKB1PNMT
SCHEMBL3182327 0.84 ADRB2 (0.53) CYP1A2CYP2D6NFKB1CYP3A4ALDH1A1
SCHEMBL31084764 0.84 ADRB2 (0.53) CYP1A2CYP2D6NFKB1CYP3A4ALDH1A1
SCHEMBL30446181 0.81 CFD (0.46) KCNH2CYP2D6NFKB1MEN1KMT2A
SCHEMBL20943296 0.81 CFD (0.46) KCNH2CYP2D6NFKB1MEN1KMT2A
SCHEMBL20943298 0.81 CFD (0.46) KCNH2CYP2D6NFKB1MEN1KMT2A
SCHEMBL166818 0.80 KCNH2 (0.54) KCNH2CYP1A2CYP2D6NFKB1PNMT
SCHEMBL7147316 0.80 KCNH2 (0.54) KCNH2CYP1A2CYP2D6NFKB1PNMT
SCHEMBL15497033 0.79 CYP1A2 (0.53) KCNH2CYP1A2CYP2D6NFKB1PNMT
SCHEMBL382016 0.79 CYP1A2 (0.53) KCNH2CYP1A2CYP2D6NFKB1PNMT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024183772-A1 CYCLIC PHOSPHATE COMPOUND AS DRUG FOR REGULATING CHOLESTEROL METABOLISM VIA LIVER DELIVERY AND USE 浙江柏拉阿图医药科技有限公司 2024-09-12 WO disclosed